Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2022 –2029 | |
|
|
USD 9.40 Billion |
| USD 40.42 Billion | |
| % | |
|
Global Next Generation DNA Sequencing (NGS) Market, By Product (Instruments, Consumables, Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical and Biotechnology Companies, Research Centers and Academic and Government Institutes, Hospital and Clinics) – Industry Trends and Forecast to 2029.
In recent years, the next generation DNA sequencing (NGS) market is anticipated to grow rapidly during the forecast period owing to the high prevalence rate of cancer. Next-generation sequencing is a DNA sequencing method that determines the exact arrangement of nucleotides within a DNA molecule. A million DNA molecules and RNA sequences are generated every second by the next-generation sequencer, enabling for rapid sequencing. Next-generation sequencing refers to high-throughput sequencing (NSG).
The method of determining the sequence of nucleotides in a piece of DNA is known as next-generation sequencing, or high-throughput sequencing. Sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing, and single-molecule real-time (SMRT) sequencing are some of the techniques used. It is a cost-effective solution that provides precise, high-accuracy, and fast outcomes.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Instruments, Consumables, Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical and Biotechnology Companies, Research Centers and Academic and Government Institutes, Hospital and Clinics)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), PerkinElmer, Inc. (US), BGI Group (China), Agilent Technologies, Inc. (US), Eurofins Scientific (Luxembourg), PacBio (US), Oxford Nanopore Technologies plc (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), GENEWIZ Inc. (US), Psomagen (South Korea), 10x Genomics (US), Takara Bio Inc (Japan), Bio-Rad Laboratories, Inc. (US), Zymo Research Corporation (US), Tecan Trading AG (Switzerland), Hamilton Company (US), Beckman Coulter, Inc. (US), BD (US), Lucigen Corporation (US), and Novogene Co., Ltd. (China)
|
|
Market Opportunities
|
|
The rising prevalence of chronic diseases such as cancer will propel the market’s growth rate during the forecast period of 2022-2029. There has been a tremendous growth in the use of NGS technology as a result of the widespread acceptance of liquid biopsies in cancer diagnoses. Cell-free circulating tumor DNA (ctDNA) is used as a non-invasive cancer biomarker for real-time cancer monitoring and detection in these technologies.
The market is also benefiting from the growing use of genomic mapping programmes to anticipate the development of various diseases. Scientists utilize genetic maps to help them figure out which genes are linked to rising rates of diabetes, heart disease, asthma, cancer, and psychiatric disorders.
Furthermore, the growing geriatric population will act as major factor influencing the growth of next generation DNA sequencing (NGS) market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the next generation DNA sequencing (NGS) market. Also, increasing expenditure on healthcare infrastructure and rising use of NGS technology by pharmaceutical and biopharmaceutical companies are the major market drivers that will further escalate the growth of next generation DNA sequencing (NGS) market.
Moreover, the market's growth is fueled by an increase in the number of research and development activities in the field of molecular biology, sequencing chemistry and technical engineering. This will provide beneficial opportunities for the next generation DNA sequencing (NGS) market growth.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the next generation DNA sequencing (NGS) market growth during the forecast period.
On the other hand, the high cost associated with next generation DNA sequencing (NGS) will obstruct the growth rate of market. The dearth of skilled professionals and rising risk of infection will challenge the next generation DNA sequencing (NGS) market. Additionally, impact of COVID-19 on supply chain and introduction of alternative technology will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This next generation DNA sequencing (NGS) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the next generation DNA sequencing (NGS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The dissemination use COVID-19 had a huge impact on numerous sectors around the world; the primary goal was to alleviate the global crisis. Pharmaceutical and biopharmaceutical industries, on the other hand, have grown tremendously as a result of pandemics. During the outbreak, developing self-test kits, therapies, and vaccinations were considered critical operations. As a result, various startups and established market players have raised their investments to support the process, assisting the next generation sequencing industry's overall growth. As a result, governmental entities have increased their research and development efforts in the next generation sequencing sector. The need of continuous supply and research was recognized by market participants, who boosted their investments in the industry as a result of the pandemic, resulting in higher Next Generation Sequencing market growth.
Recent Development
The next generation DNA sequencing (NGS) market is segmented on the basis of product, applications and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
Based on product, next generation DNA sequencing (NGS) market is segmented into instruments, consumables, and services.
Applications
On the basis of application, next generation DNA sequencing (NGS) market is segmented into diagnostics, biomarker discovery, precision medicine, drug discovery, agriculture and animal research and others.
End User
Next generation DNA sequencing (NGS) market has also been segmented based on the end user into pharmaceutical and biotechnology companies, research centers and academic and government institutes, hospital and clinics.
The next generation DNA sequencing (NGS) market is analysed and market size insights and trends are provided by country, product, applications and end user as referenced above.
The countries covered in the next generation DNA sequencing (NGS) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the next generation DNA sequencing (NGS) market because of the well-established healthcare infrastructure and increasing awareness about advanced treatment methods in this region. Additionally, presence of major key players will flourish the market’s growth rate in this region.
Asia-Pacific is expected to grow during the forecast period due to rising prevalence of genetic diseases and growing awareness on reproductive health in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The next generation DNA sequencing (NGS) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for next generation DNA sequencing (NGS) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the next generation DNA sequencing (NGS) market. The data is available for historic period 2010-2020.
The Next generation DNA sequencing (NGS) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to next generation DNA sequencing (NGS) market.
Some of the major players operating in the next generation DNA sequencing (NGS) market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.